1.31
price down icon2.96%   -0.04
after-market Handel nachbörslich: 1.31
loading
Schlusskurs vom Vortag:
$1.35
Offen:
$1.34
24-Stunden-Volumen:
467.51K
Relative Volume:
0.81
Marktkapitalisierung:
$175.38M
Einnahmen:
$108.81M
Nettoeinkommen (Verlust:
$-186.70M
KGV:
-1.5558
EPS:
-0.842
Netto-Cashflow:
$-16.83M
1W Leistung:
-4.38%
1M Leistung:
+13.91%
6M Leistung:
-13.82%
1J Leistung:
-23.39%
1-Tages-Spanne:
Value
$1.30
$1.35
1-Wochen-Bereich:
Value
$1.30
$1.38
52-Wochen-Spanne:
Value
$0.85
$2.08

Organigram Global Inc Stock (OGI) Company Profile

Name
Firmenname
Organigram Global Inc
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
1,150
Name
Twitter
@discoverogi
Name
Nächster Verdiensttermin
2024-08-13
Name
Neueste SEC-Einreichungen
Name
OGI's Discussions on Twitter

Vergleichen Sie OGI mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - Specialty & Generic icon
OGI
Organigram Global Inc
1.31 178.74M 108.81M -186.70M -16.83M -0.842
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
11.41 50.54B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
169.42 74.02B 9.29B 2.52B 2.28B 5.57
Drug Manufacturers - Specialty & Generic icon
RDHL
Redhill Biopharma Ltd Adr
1.80 4.22M 35.75M 11.57M -26.25M -3.8069
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
15.08 45.82B 30.08B 710.16M 4.45B 0.2182
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
17.26 20.31B 16.54B -1.64B 749.00M -1.45

Organigram Global Inc Stock (OGI) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-07-17 Fortgesetzt Canaccord Genuity Speculative Buy
2024-04-15 Hochstufung Alliance Global Partners Neutral → Buy
2023-01-13 Hochstufung Stifel Hold → Buy
2022-01-12 Hochstufung Canaccord Genuity Hold → Speculative Buy
2021-05-11 Hochstufung CIBC Sector Underperform → Neutral
2021-04-14 Herabstufung CIBC Neutral → Sector Underperform
2021-04-08 Hochstufung BMO Capital Markets Underperform → Market Perform
2021-03-10 Herabstufung BMO Capital Markets Market Perform → Underperform
2021-01-13 Herabstufung Alliance Global Partners Buy → Neutral
2021-01-13 Herabstufung Canaccord Genuity Speculative Buy → Hold
2020-07-07 Eingeleitet Alliance Global Partners Buy
2020-01-15 Hochstufung Raymond James Mkt Perform → Outperform
2020-01-13 Eingeleitet BofA/Merrill Underperform
2020-01-09 Herabstufung Raymond James Outperform → Mkt Perform
2019-11-12 Herabstufung BMO Capital Markets Outperform → Market Perform
2019-11-05 Eingeleitet Cantor Fitzgerald Overweight
2019-10-11 Hochstufung Jefferies Hold → Buy
Alle ansehen

Organigram Global Inc Aktie (OGI) Neueste Nachrichten

pulisher
May 29, 2025

Organigram CEO Beena Goldenberg to retire - MSN

May 29, 2025
pulisher
May 28, 2025

How I Built Canada’s Biggest Cannabis Company - Canadian Business

May 28, 2025
pulisher
May 27, 2025

Organigram CEO To Retire After Building Canada's Largest Cannabis Brand: Here's What's Next - Benzinga

May 27, 2025
pulisher
May 27, 2025

Germany Has Become The World's Largest Cannabis Importer: Here Are The Stocks Benefiting - Benzinga

May 27, 2025
pulisher
May 27, 2025

Organigram begins process to find new CEO with Beena Goldenberg stepping down - StratCann

May 27, 2025
pulisher
May 27, 2025

Organigram Global Announces CEO Succession Plan - mg Magazine

May 27, 2025
pulisher
May 27, 2025

Goldenberg retiring as CEO of cannabis producer Organigram - MJBizDaily

May 27, 2025
pulisher
May 27, 2025

Organigram (OGI) CEO Beena Goldenberg Announces Retirement | OGI Stock News - GuruFocus

May 27, 2025
pulisher
May 27, 2025

Organigram (OGI) CEO Beena Goldenberg to Retire in 2025 - GuruFocus

May 27, 2025
pulisher
May 27, 2025

Organigram Global Announces CEO Succession Amidst Strong Growth - TipRanks

May 27, 2025
pulisher
May 27, 2025

Organigram Global Announces CEO Succession Plan | OGI Stock News - GuruFocus

May 27, 2025
pulisher
May 27, 2025

Organigram Brief: Announcing CEO Succession Plan;B eena Goldenberg, CEO to Retire At End of the Company's fiscal year - marketscreener.com

May 27, 2025
pulisher
May 27, 2025

3 Reasons to Buy Realty Income Stock Like There's No Tomorrow - The Globe and Mail

May 27, 2025
pulisher
May 20, 2025

Decibel Cannabis stock is a worthwhile purchase, Haywood says - Mugglehead Magazine

May 20, 2025
pulisher
May 16, 2025

This Week In Cannabis: Earnings Season, Uruguay's 'Pepe' Mujica's Legacy, DEA's Meme Backlash, California's Tax Hike, The DEA's Stance And More - Benzinga

May 16, 2025
pulisher
May 16, 2025

Organigram Global Reports Record Q2 2025 Revenues As Global Footprint Expands - Seeking Alpha

May 16, 2025
pulisher
May 14, 2025

Buy Organigram for big returns, Haywood says - Cantech Letter

May 14, 2025
pulisher
May 13, 2025

Organigram Reports Second Quarter Fiscal 2025 Results - mg Magazine

May 13, 2025
pulisher
May 13, 2025

Organigram Global Inc. (NASDAQ:OGI) Q2 2025 Earnings Call Transcript - Insider Monkey

May 13, 2025
pulisher
May 13, 2025

Organigram reports record Q2 fiscal 2025 results | 2025-05-12 | Investing News - Stockhouse

May 13, 2025
pulisher
May 13, 2025

Organigram Global Inc (OGI) Q2 2025 Earnings Call Highlights: Record Revenue and Strategic Expansion - Yahoo Finance

May 13, 2025
pulisher
May 12, 2025

Organigram Global’s Earnings Call Highlights Growth and Market Leadership - TipRanks

May 12, 2025
pulisher
May 12, 2025

OrganiGram (OGI) Reports Q2 Loss, Beats Revenue Estimates (Revised) - Yahoo Finance

May 12, 2025
pulisher
May 12, 2025

OrganiGram: Fiscal Q2 Earnings Snapshot - MySA

May 12, 2025
pulisher
May 12, 2025

Organigram has sights set on global expansion after ‘record’ quarter - BNN Bloomberg

May 12, 2025
pulisher
May 12, 2025

Organigram reports spike in sales, revenue from Motif acquisition - StratCann

May 12, 2025
pulisher
May 12, 2025

Organigram Q2 2025 Earnings Call Transcript - MarketBeat

May 12, 2025
pulisher
May 12, 2025

OrganiGram Q2 2025 presentation slides: record revenue, strategic acquisitions fuel growth - Investing.com India

May 12, 2025
pulisher
May 12, 2025

Earnings call transcript: OrganiGram’s Q2 2025 revenue surges 74% By Investing.com - Investing.com Nigeria

May 12, 2025
pulisher
May 12, 2025

Organigram Lights Up Q2 With 74% Sales Surge, Profitable TurnOrganigram Global (NASDAQ:OGI) - Benzinga

May 12, 2025
pulisher
May 12, 2025

Organigram reports record Q2 fiscal 2025 results - MSN

May 12, 2025
pulisher
May 12, 2025

Earnings call transcript: OrganiGram’s Q2 2025 revenue surges 74% - Investing.com

May 12, 2025
pulisher
May 12, 2025

OrganiGram (OGI) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Finance

May 12, 2025
pulisher
May 12, 2025

Organigram Q2 Was Better Than Expected - New Cannabis Ventures

May 12, 2025
pulisher
May 12, 2025

Organigram Reports Record Second Quarter Fiscal 2025 Results | O - GuruFocus

May 12, 2025
pulisher
May 12, 2025

Organigram Reports Record Second Quarter Fiscal 2025 Results | OGI Stock News - GuruFocus

May 12, 2025
pulisher
May 12, 2025

Organigram Reports Record Second Quarter Fiscal 2025 Results - Business Wire

May 12, 2025
pulisher
May 11, 2025

Weekly Roundup on the Cannabis Sector & Psychedelic Sector - marketexclusive.com

May 11, 2025
pulisher
May 11, 2025

SA Asks: What are the best cannabis stocks right now? (CGC:NASDAQ) - Seeking Alpha

May 11, 2025
pulisher
May 11, 2025

Is It Time to Turn Bullish on AMD Stock? - The Globe and Mail

May 11, 2025
pulisher
May 07, 2025

Organigram’s Collective Project Wins Big at 2025 High Spirits Awards - TipRanks

May 07, 2025
pulisher
May 07, 2025

Organigram Global's Collective Project Wins Big at the 2025 High Spirits Awards in California | OGI Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Organigram Global’s Collective Project Wins Big at the 2025 High Spirits Awards in California - Business Wire

May 07, 2025
pulisher
May 06, 2025

Organigram Global Wins ‘Exporter of the Year’ at 2025 New Brunswick Export Awards - mg Magazine

May 06, 2025

Finanzdaten der Organigram Global Inc-Aktie (OGI)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$8.69
price down icon 1.14%
drug_manufacturers_specialty_generic HCM
$13.60
price down icon 2.09%
drug_manufacturers_specialty_generic RDY
$14.74
price up icon 0.14%
$124.56
price up icon 1.25%
$325.48
price up icon 2.08%
$17.26
price up icon 2.86%
Kapitalisierung:     |  Volumen (24h):